Skip to content

Opus Genetics, Inc.: 10-K filed 2014-03-21

What Opus Genetics, Inc. reported in its annual report filed 2014-03-21 (fiscal FY 2013): 24 published measures, 92 facts as tagged in accession 0001140361-14-013828.

This filing

Form
10-K (annual report)
Filed
2014-03-21
Fiscal period
fiscal FY 2013
Accession
0001140361-14-013828 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Opus Genetics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-12-3119,556,498USD
At 2012-12-3114,919,308USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-12-316,931,010USD
At 2012-12-315,385,319USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-12-3112,625,488USD
At 2012-12-319,533,989USD
At 2011-12-3110,706,130USD
At 2010-12-3110,395,457USD
At 2009-12-314,902,411USD
At 2008-12-31-2,602,689USD
At 2007-12-31958,193USD
At 2006-12-313,213,847USD
At 2005-12-314,829,496USD
At 2004-12-31-564,171USD
At 2003-12-312,476,701USD
At 2002-12-312,713,702USD
At 2001-12-313,894,859USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-12-3118,688,031USD
At 2012-12-3113,486,543USD
At 2011-12-319,861,488USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-9,499,424USD365
2001-03-19 to 2013-12-31-72,810,707USD4671
2012-01-01 to 2012-12-31-6,226,670USD366
2011-01-01 to 2011-12-31-11,344,950USD365
2010-01-01 to 2010-12-31-14,022,107USD365
2009-01-01 to 2009-12-31-2,903,098USD365
2008-01-01 to 2008-12-31-3,681,801USD366
2007-01-01 to 2007-12-31-4,442,331USD365
2006-01-01 to 2006-12-31-6,486,003USD365
2005-01-01 to 2005-12-31-6,349,540USD365
2004-01-01 to 2004-12-31-3,273,442USD366
2003-01-01 to 2003-12-31-2,775,075USD365
2002-01-01 to 2002-12-31-1,181,157USD365
2001-03-19 to 2001-12-31-625,109USD288

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2013-01-01 to 2013-12-310USD365
2001-03-19 to 2013-12-310USD4671
2012-01-01 to 2012-12-310USD366

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2013-01-01 to 2013-12-3112,340,822USD365
2001-03-19 to 2013-12-3186,574,055USD4671
2012-01-01 to 2012-12-318,054,650USD366

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2013-01-01 to 2013-12-31845,522USD365
2001-03-19 to 2013-12-31-1,280,791USD4671
2012-01-01 to 2012-12-312,189,964USD366

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2013-01-01 to 2013-12-310USD365
2001-03-19 to 2013-12-310USD4671
2012-01-01 to 2012-12-310USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2013-12-3165,172USD
At 2012-12-3152,156USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2013-01-01 to 2013-12-31565,428USD365
2001-03-19 to 2013-12-316,374,044USD4671
2012-01-01 to 2012-12-31230,987USD366

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-7,978,838USD365
2001-03-19 to 2013-12-31-76,532,508USD4671
2012-01-01 to 2012-12-31-6,579,530USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2013-12-3119,295,196USD
At 2012-12-3113,775,351USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2001-03-19 to 2013-12-3128,410USD4671

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2013-01-01 to 2013-12-317,978,838USD365
2001-03-19 to 2013-12-3176,532,508USD4671
2012-01-01 to 2012-12-316,579,530USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2013-01-01 to 2013-12-313,253,139USD365
2001-03-19 to 2013-12-3138,531,638USD4671
2012-01-01 to 2012-12-313,392,896USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-12-31146,717,795shares
At 2012-12-31119,428,989shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2013-12-31645,921USD
At 2012-12-31665,376USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2013-12-31580,749USD
At 2012-12-31613,220USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2013-12-31507,165USD
At 2012-12-31188,808USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-01-01 to 2013-12-314,260,363USD365
2001-03-19 to 2013-12-3134,320,507USD4671
2012-01-01 to 2012-12-312,713,149USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2013-01-01 to 2013-12-3137,133USD365
2012-01-01 to 2012-12-3142,386USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2013-01-01 to 2013-12-31-1,520,586USD365
2001-03-19 to 2013-12-313,721,801USD4671
2012-01-01 to 2012-12-31352,860USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2013-10-15 to 2013-10-165,300,001USD2
2013-07-25 to 2013-07-265,700,000USD2
2012-12-09 to 2012-12-107,260,000USD2
2012-12-06 to 2012-12-07750,000USD2
2012-12-03 to 2012-12-047,260,000USD2
2011-03-30 to 2011-03-3110,000,000USD2
2011-01-18 to 2011-01-193,926,397USD2
2010-06-29 to 2010-06-3010,000,000USD2
2009-10-22 to 2009-10-235,000,000USD2
2009-09-20 to 2009-09-213,371,340USD2
2009-06-04 to 2009-06-053,000,000USD2
2008-03-19 to 2008-03-20900,001USD2
2007-12-17 to 2007-12-186,800,023USD2

Inspect the source

Entity
Opus Genetics, Inc. / CIK 0001228627
Captured
2026-09-20T07:46:24.028Z
SEC response SHA-256
59b3f548361fa5c66fb8bd927bac9bc7dc8822bcce158860c7c4d77974af0a92

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001228627.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))